IRCCS San Raffaele Roma clinical trials
IRCCS San Raffaele Roma is the lead sponsor of 22 current clinical trials in our Italy, Spain and Czechia registers. 15 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Eptinezumab. The most-studied condition is Stroke.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by IRCCS San Raffaele Roma
22 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Bilateral Robot-assisted Upper Extremity Rehabilitation on Motor Recovery in People With Subacute Stroke
NCT06906588 · ClinicalTrials.gov ↗ · Stroke, Sabacute Stroke
|
Not applicable | Recruiting | 2024-05 | Italy |
|
Interactive Intensive Gait Training in Walking Limitations
NCT07899528 · ClinicalTrials.gov ↗ · Neurologic Ambulation Disorder
|
Not applicable | Recruiting | 2026-10 | Italy |
|
Robotic Rehabilitation of the Upper Limb in Subacute Stroke
NCT06839482 · ClinicalTrials.gov ↗ · Stroke
|
Not applicable | Recruiting | 2025-02 | Spain, Italy, Czechia |
|
Prevalence of Sarcopenic Obesity in COPD
NCT06822504 · ClinicalTrials.gov ↗ · Sarcopenic Obesity, COPD
|
Observational | Recruiting | 2024-06 | Italy |
|
Psychologically Informed Telerehabilitation for Fibromyalgia
NCT07865403 · ClinicalTrials.gov ↗ · Fibromyalgia
|
Not applicable | Recruiting | 2026-09 | Italy |
|
Correlation Between Clinical Neurological Biomarkers and Rehabilitation Outcome
NCT06805929 · ClinicalTrials.gov ↗ · Stroke
|
Observational | Recruiting | 2020-06 | Italy |
|
Monitoring Daily Mobility in Children With Autism
NCT07519369 · ClinicalTrials.gov ↗ · Autism Spectrum Disorder (ASD
|
Not applicable | Recruiting | 2026-02 | Italy |
|
EptinezuMaB in ReAl-world evidenCE: Multicenter, Real Life, Cohort Study in Migraine.
NCT05570149 · ClinicalTrials.gov ↗ · Migraine Disorders
Drug: Eptinezumab |
Observational | Recruiting | 2023-01 | Italy |
|
Kinematic Analysis of Manual Dexterity
NCT07875127 · ClinicalTrials.gov ↗ · Down Syndrome, Hemiparesis, Healthy Subjects
|
Observational | Recruiting | 2024-05 | Italy |
|
AIDE: Decision Support for Anastomosis or Colostomy in Emergency Surgery for Complicated Acute Diverticulitis
NCT07651072 · ClinicalTrials.gov ↗ · Complicated Diverticulitis, Acute Diverticulitis, Peritonitis
|
Observational | Recruiting | 2026-05 | Italy |
|
(Italian Migraine Registry, I-GRAINE-NEW)
NCT07163416 · ClinicalTrials.gov ↗ · Migraine Disorders
|
Observational | Recruiting | 2021-04 | Italy |
|
i-NEED: NEw migrainE Drugs Database
NCT07103694 · ClinicalTrials.gov ↗ · Episodic Migraine, Chronic Migraine, Medication Overuse Headache
|
Observational | Recruiting | 2022-03 | Italy |
|
Cervical tsDCS on Stroke Patients
NCT06826274 · ClinicalTrials.gov ↗ · Functional Recovery, Motor Rehabilitation
|
Not applicable | Recruiting | 2026-03 | Italy |
|
Drug Management in Heart Failure
NCT06915584 · ClinicalTrials.gov ↗ · Heart Failure
|
Observational | Recruiting | 2024-11 | Italy |
|
Risk of Falling and Cardiac Rehabilitation
NCT06908759 · ClinicalTrials.gov ↗ · Risk of Falling, Elderly (People Aged 65 or More), Cardiovascular Diseases
|
Not applicable | Recruiting | 2024-05 | Italy |
|
Evaluation of a Soft Elbow Exoskeleton and a Haptic Armband in Post-stroke and Parkinson's Disease Patients
NCT07637123 · ClinicalTrials.gov ↗ · Stroke, Parkinson Disease
|
Not applicable | Not yet open | 2026-06 | Italy |
|
VisMemoPD Protocol: an Observational Pilot Study on Spatial and Topographical Memory in Patients With Parkinson's Disease and Parkinsonism
NCT07827963 · ClinicalTrials.gov ↗ · Parkinson's Disease, Parkinsonism, Multiple System Atrophy
|
Observational | Not yet open | 2026-09 | Italy |
|
Parkinson's Research In Metagenomic Early Stage Biomarkers
NCT07097103 · ClinicalTrials.gov ↗ · Parkinson's Disease (PD)
|
Not applicable | Not yet open | 2026-09 | Italy |
|
Biomarkers in Alzheimer's and Parkinson's Diseases for IA
NCT07651085 · ClinicalTrials.gov ↗ · Parkinson Disease, Alzheimer Disease, Mild Cognitive Impairment
|
Observational | Active, closed | 2024-02 | Italy |
|
Brain Connectivity Analysis
NCT06823102 · ClinicalTrials.gov ↗ · Neural Injury
|
Not applicable | Active, closed | 2023-04 | Italy |
|
Tele-rehabilitation Program in People With Multiple Sclerosis and Mild Disability
NCT07924410 · ClinicalTrials.gov ↗ · Multiple Sclerosis, Fatigue in Multiple Sclerosis
|
Not applicable | Active, closed | 2025-11 | Italy |
|
Gait Training Through a Novel Over-ground Wearable Robotic System in People With Pyramidal Hemisyndromes
NCT04559724 · ClinicalTrials.gov ↗ · Stroke, Brain Injuries, Traumatic, Brain Tumor Benign
|
Not applicable | Active, closed | 2020-09 | Italy |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Drugs in IRCCS San Raffaele Roma trials
1 compoundDrugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
Conditions in IRCCS San Raffaele Roma trials
38 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Italy | 22 | 15 |
| Clinical trials in Spain | 1 | 1 |
| Clinical trials in Czechia | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Stroke
Sponsors with the most current trials registered for this condition.
Questions about IRCCS San Raffaele Roma trials
How many clinical trials does IRCCS San Raffaele Roma sponsor?
IRCCS San Raffaele Roma is the lead sponsor of 22 current trials on ClinicalTrials.gov in our Italy, Spain and Czechia registers, as of the registry sync on 12 November 2026. Completed and withdrawn studies are not counted.
Are IRCCS San Raffaele Roma trials recruiting?
Yes. 15 of its 22 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Which drugs is IRCCS San Raffaele Roma testing?
Its current trials name 1 drug or biological as interventions. The most frequent are Eptinezumab (1). The number in brackets is how many of its trials name each drug.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 12 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.